Targeting LINC00152 activates cAMP/Ca(2+)/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.

Saatci O, Alam R, Huynh-Dam KT, Isik A, Uner M, Belder N, Ersan PG, Tokat UM, Ulukan B, Cetin M, Calisir K, Gedik ME, Bal H, Sener Sahin O, Riazalhosseini Y, Thieffry D, Gautheret D, Ogretmen B, Aksoy S, Uner A, Akyol A, Sahin O
Cell Death Dis. 2024 Jun 15;15(6):418. doi: 10.1038/s41419-024-06814-3. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.